Modeling and Meta-Analysis

Simulating Outcomes Beyond Trials

Models & Meta-Analyses (MMA) are powerful tools for making comprehensive assessments of the costs and benefits of healthcare interventions beyond clinical trials. Health economic models provide vital information to inform allocation of available resources for maximizing health benefits. Meta-analyses are powerful tools for synthesizing multiple studies to improve the precision and relevance of clinical and health outcomes data.

Our models are designed to be user-friendly and easily adaptable. We use Excel-based interfaces, web-based dashboards in dedicated software, and detailed, transparent documentation of complex simulations to make our models accessible for the intended audience.

Why Pharmerit?

High-quality deliverables meeting HTA requirements

Multidisciplinary, dedicated teams including senior team members and experienced clinicians working on value communication/dossier development

Experienced HEOR and clinical researchers with a strategic focus, who are able to combine and interpret burden of illness, treatment pathway, clinical and economic evidence in order to support a product’s value communication and reimbursement strategy

Partnering with clients on products and portfolios from clinical development, launch, and post-launch

Innovative solutions to present and communicate the value of your product by interactive tools to visualize and highlight findings

Resources

”We were looking for skills and resources to address our question for an indirect comparison/network meta-analysis. Pharmerit has successfully addressed our research needs. We already had positive experience in working with them as a preferred provider. Pharmerit provides clear and smooth communication, good staff capabilities and complies with project timelines.”